Navigating the current landscape of scientific publishing – the Molecular Oncology perspective

Ryan, K. M. (2022) Navigating the current landscape of scientific publishing – the Molecular Oncology perspective. Molecular Oncology, 16(12), pp. 2297-2299. (doi: 10.1002/1878-0261.13271) (PMID:35723239) (PMCID:PMC9208072)

[img] Text
273554.pdf - Published Version
Available under License Creative Commons Attribution.



With your experiments and analyses completed, thoughts turn to writing up your work and submitting for publication. This cycle has not changed for decades, but in recent years there has been an exponential increase in the number of journal options in any given field. So, how do you choose the best journal for you? Terms such as subscription journal, hybrid journal, open access journal and society journal are ones that we all hear, but what does it all mean? Within this short commentary, I highlight several aspects of publishing that are worth considering when choosing which journal to submit your work. The perspectives are admittedly written from the office of Molecular Oncology, but the comments also represent an objective view from an academic scientist, which could be applied to many areas of science.

Item Type:Articles (Editorial)
Glasgow Author(s) Enlighten ID:Ryan, Professor Kevin
Authors: Ryan, K. M.
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
Journal Name:Molecular Oncology
ISSN (Online):1878-0261
Published Online:20 June 2022
Copyright Holders:Copyright © 2022 The Authors
First Published:First published in Molecular Oncology 16(12):2297-2299
Publisher Policy:Reproduced under a Creative Commons license

University Staff: Request a correction | Enlighten Editors: Update this record